Sg Americas Securities, LLC Exelixis, Inc. Transaction History
Sg Americas Securities, LLC
- $24.1 Billion
- Q2 2025
A detailed history of Sg Americas Securities, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 69,617 shares of EXEL stock, worth $2.61 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
69,617
Previous 567,653
87.74%
Holding current value
$2.61 Million
Previous $21 Million
85.36%
% of portfolio
0.01%
Previous 0.07%
Shares
30 transactions
Others Institutions Holding EXEL
# of Institutions
674Shares Held
262MCall Options Held
1.58MPut Options Held
1.17M-
Black Rock Inc. New York, NY33.5MShares$1.26 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA27.5MShares$1.03 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA16MShares$602 Million3.18% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.8MShares$594 Million0.99% of portfolio
-
State Street Corp Boston, MA11.4MShares$427 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $12.1B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...